Lyka Labs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE933A01014
  • NSEID: LYKALABS
  • BSEID: 500259
INR
92.52
1.81 (2.0%)
BSENSE

Nov 20

BSE+NSE Vol: 48.45 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryLyka Labs VS Pharmaceuticals & Biotechnology
 
1D
2%
1.08%
1W
9.82%
2.85%
1M
6.34%
13.63%
YTD
21.74%
-1.53%
1Y
15.87%
-2%
3Y
-28.78%
27.82%
5Y
-21.02%
40.72%
10Y
75.56%
220.91%
  • Stock Absolute Returns
  • Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
28.46%
0%
28.46%
6 Months
0%
0%
0.0%
1 Year
15.87%
0%
15.87%
2 Years
-35.35%
0%
-35.35%
3 Years
-28.78%
0%
-28.78%
4 Years
-25.63%
0%
-25.63%
5 Years
-21.02%
0%
-21.02%

Lyka Labs for the last several years.

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Industry stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Market Cap stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
stock-summaryRisk Adjusted Returns v/s
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available